Cardioprotective Effects of Dorzagliatin Against Streptozotocin-induced Diabetic Cardiomyopathy: Involvement of Anti-hyperlipidemic, Antioxidant, and Anti-inflammatory Mechanisms
Diabetic cardiomyopathy (DCM) represents a critical clinical problem, manifesting as progressive functional and structural myocardial impairment independent of traditional cardiovascular comorbidities such as hypertension or coronary artery disease. Current treatment options largely rely on conventional heart failu...